View of BISPECIFIC ANTIBODIES IN RELAPSED REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC REVIEW OF EFFICACY AND SAFETY IN PHASE I/II/III CLINICAL TRIAL

Return to Article Details BISPECIFIC ANTIBODIES IN RELAPSED REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC REVIEW OF EFFICACY AND SAFETY IN PHASE I/II/III CLINICAL TRIAL Download Download PDF